EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tracking and curating putative SARS-CoV-2 recombinants with RIVET

Kyle Smith, Cheng Ye, Yatish Turakhia iD

Bioinformatics · 2023

DOI: 10.1093/bioinformatics/btad538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, 2023. Verfasst von Kyle Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of California, San Diego, San Diego, CA 92093, United States. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Identifying and tracking recombinant strains of SARS-CoV-2 is critical to understanding the evolution of the virus and controlling its spread. But confidently identifying SARS-CoV-2 recombinants from thousands of new genome sequences that are being shared online every day is quite challenging, causing many recombinants to be missed or suffer from weeks of delay in being formally identified while undergoing expert curation. Results We present RIVET—a software pipeline and visual platform that takes advantage of recent algorithmic advances in recombination inference to comprehensively and sensitively search for potential SARS-CoV-2 recombinants and organize the relevant information in a web interface that would help greatly accelerate the process of identifying and tracking recombinants. Availability and implementation RIVET-based web interface displaying the most updated analysis of potential SARS-CoV-2 recombinants is available at https://rivet.ucsd.edu/. RIVET’s frontend and backend code is freely available under the MIT license at https://github.com/TurakhiaLab/rivet and the documentation for RIVET is available at https://turakhialab.github.io/rivet/. The inputs necessary for running RIVET’s backend workflow for SARS-CoV-2 are available through a public database maintained and updated daily by UCSC (https://hgdownload.soe.ucsc.edu/goldenPath/wuhCor1/UShER_SARS-CoV-2/).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Databases, FactualDocumentationSoftware

Autor:innen und Institutionen

  • Department of Biological Sciences, University of California, San Diego, San Diego, CA 92093, United States.
  • Department of Electrical and Computer Engineering, University of California, San Diego, San Diego, CA 92093, United States.

ORCID-Profile: Yatish Turakhia

Förderung

  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Smith, K., Ye, C., & Turakhia, Y. (2023). Tracking and curating putative SARS-CoV-2 recombinants with RIVET. Bioinformatics. https://doi.org/10.1093/bioinformatics/btad538

Vancouver

Smith K, Ye C, Turakhia Y. Tracking and curating putative SARS-CoV-2 recombinants with RIVET. Bioinformatics. 2023. doi:10.1093/bioinformatics/btad538

BibTeX
@article{Smith2023,
  author = {Smith, Kyle and Ye, Cheng and Turakhia, Yatish},
  title = {Tracking and curating putative SARS-CoV-2 recombinants with RIVET},
  journal = {Bioinformatics},
  year = {2023},
  doi = {10.1093/bioinformatics/btad538}
}
Kostenlos starten →